27
Feb
Related Posts
12
Oct
PRODIA CLINICAL LAB RECEIVED THE CAP ACCREDITATION
Prodia Clinical Laboratory – which is the largest and the best independent laboratory in Indonesia achieved The College of... read more
10
Apr
SMO – PT. Prodia DiaCRO Laboratories Signed the MoU with RSUP Dr. M. Djamil Padang, Indonesia
PT. Prodia DiaCRO Laboratories collaborated with RSUP Dr. M. Djamil Padang to develop the trial site capacity building. This... read more
02
Mar
Top 10 Clinical Trial Management Consulting/Service Companies in APAC – 2020
Top 10 Clinical Trial Management Consulting/Service Companies in APAC – 2020 linical research and trials are... read more
19
Feb
Prodia The CRO: Course and Workshop on Good Clinical Practice (GCP) in Faculty of Dentistry, Trisakti University
JAKARTA – The Course and Workshop on Good Clinical Practice (GCP) was held by PT. Prodia Diacro Laboratories (Prodia... read more
13
Jan
SMO – PT. Prodia DiaCRO Laboratories Signed the MoU with RSUP Dr. Hasan Sadikin
Development of SMO in Prodia has brought the trial site capacity building program established between PT. Prodia DiaCRO Laboratories... read more
29
Sep
Prodia The CRO: Course and Workshop on Good Clinical Practice (GCP) in RSUP Dr. Hasan Sadikin
BANDUNG – The Course and Workshop on Good Clinical Practice (GCP) was held by PT. Prodia Diacro Laboratories (Prodia... read more
12
Oct
Dynavax Heplisav shows superiority over Engerix-B in diabetics
Dynavax Technologies, a biopharmaceutical company, has reported positive results of Phase 3 trial (HBV-16), demonstrating the superiority of Heplisav... read more
01
Dec
Prodia the CRO, 2014 Frost and Sullivan Indonesia Contract Research Organization of The Year
The Frost and Sullivan Indonesia CRO of the Year award is presented to the leading company that has shown... read more
24
Jul
Prodia the CRO as top 10 Clinical trial Services Companies in APAC-2019
Top 10 Clinical Trial Services Companies in APAC – 2019 he clinical trial industry is going... read more
12
Oct
Catabasis begins clinical trial on CAT-1004 drug candidte
Catabasis Pharmaceuticals has commenced the phase 1 clinical trial for its product candidate CAT-1004 to treat patients with type... read more
Leave a Reply